Health
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss - The Philadelphia Inquirer
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, whether they utilize weight loss drugs or not,” IBX said in a statement.
By: The Philadelphia Inquirer
- Dec 26 2024
- 0
- 0 Views
Starting in the new year, Independence Blue Cross, the regions largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when theyre prescribed solely for weight loss.
… [+5798 chars]